Rapport Therapeutics, Inc. (RAPP)
29.76
-0.23
(-0.77%)
USD |
NASDAQ |
Feb 20, 16:00
29.73
-0.03
(-0.10%)
Pre-Market: 20:00
Rapport Therapeutics EPS Diluted (Quarterly) : -0.7098 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bridgebio Oncology Therapeutics, Inc. | -1.029 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.92M |
| Total Expenses (Quarterly) | 26.92M |
| Enterprise Value | 584.92M |
| Earnings Yield | -9.05% |
| Normalized Earnings Yield | -9.047 |